Randi Schochet Named Chief Marketing Officer at Digital Reasoning to Navigate AI Leader into the Next Phase of Growth in Financial, Healthcare Sectors

NASHVILLE, Aug. 22, 2019 (GLOBE NEWSWIRE) — Digital Reasoning, a leader in Artificial Intelligence (AI) and Machine Learning that understands human communications and behaviors, today announced the hiring of Randi Schochet as chief marketing officer (CMO). In this new role, Schochet will build upon Digital Reasoning’s rapid growth in financial […]

Romero Group Select Applied Epic to Support Five-Year Strategic Growth Plans

Brighton, UK, Aug. 22, 2019 (GLOBE NEWSWIRE) — Applied Systems today announced that Romero Group has selected Applied Epic®, the world’s most widely used broker management system, to digitally transform their business. Utilising Applied Epic as part of the Applied Digital Broker solution, Romero Insurance Brokers, Club Insure & NDML […]

NuCana Reports Second Quarter 2019 Financial Results and Provides Business Update

Numerous Clinical Data Announcements and Study Initiations Expected in 2019 Current Cash Balance Expected to Fund the Company Into 2021 EDINBURGH, United Kingdom, Aug. 21, 2019 (GLOBE NEWSWIRE) — NuCana plc (NASDAQ: NCNA) announced financial results for the second quarter ended June 30, 2019 and provided an update on its […]

Royalton Grenada Resort and Spa to open in March 2020

TALLAHASSEE, Fla., Aug. 21, 2019 (GLOBE NEWSWIRE) — Royalton Luxury Resorts is pleased to announce that the highly-anticipated  Royalton Grenada Resort and Spa will welcome its first guests as of March 1, 2020. The opening of the resort follows the chain’s expansion in the islands of the Eastern Caribbean, offering […]

SHINKEI Therapeutics Announces Investigational New Drug Application Submission for MR-201, a Novel Dosage Form for Treatment of Pseudobulbar Affect

PRINCETON, N.J., Aug. 21, 2019 (GLOBE NEWSWIRE) — SHINKEI Therapeutics, a clinical stage pharmaceutical company focused on the development of drugs for the treatment of Central Nervous System (CNS) disorders, today announced the filing of an Investigational New Drug (“IND”) application with the U.S. Food and Drug Administration (“FDA”) of […]